Nasdaq

Abbott (ABT) Expands in Canada With First Eterna SCS Use

Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management. The ...
Seeking Alpha

Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options

ABBOTT PARK, Ill., May 16, 2023 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of ...
Pharmabiz

Five-year data shows Abbott neuromodulation systems reduce healthcare visits related to pain and deliver sustained relief

Abbott announced new five-year data demonstrating that its neuromodulation therapies, including its proprietary BurstDR spinal cord stimulation (SCS) waveform and dorsal root ganglion stimulation ...